In the version of the article “Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update” by Mosca et al that published online before print on February 19, 2007 (DOI: 10.1161/CIRCULATIONAHA.107.181546), several changes were required. The following updates have been made to the version of the article that published in the March 20, 2007, issue of Circulation (Circulation. 2007;115:1481–1501) and to the current online version of this article:
In Consultant/Advisory Board column of the Writing Group Disclosure table on page 1490, “Sanofi-Averitis” has been changed to “Sanofi-Aventis” in the disclosures for Dr Mosca.
In the Reviewer Disclosure table on page 1492, the disclosures for Dr Blumenthal have been changed. In the Research Grant column, “None” was changed to “Pfizer*; Merck*; General Electric*.” The entries in the Other Research Support and Consultant/Advisory Board columns were changed to “None.”
The footnote for the Reviewer Disclosure table has been updated.